Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
Sponsor: Theresa Jacob, PhD, MPH
Summary
This is a double blind active placebo controlled clinical trial for individuals within an inpatient setting with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.
Official title: Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 88 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-10-16
Completion Date
2026-09-30
Last Updated
2024-12-31
Healthy Volunteers
No
Conditions
Interventions
nebulized ketamine
The formulation of the study drug is administered via nebulizer in which the participants inhales the study drug. The dosage is calculated by body weight (1.5mg/kg).
Locations (1)
Maimonides Medical Center
Brooklyn, New York, United States